Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
ConclusionsThis study highlights differences concerning how IPF patients are treated in Finland and Sweden. How these differences will influence the long-term outcome of these patients is unknown.
Source: Multidisciplinary Respiratory Medicine - Category: Respiratory Medicine Source Type: research
More News: Carbon Monoxide Poisoning | Finland Health | Lung Transplant | Respiratory Medicine | Smokers | Study | Sweden Health | Transplants